Increased cortisol awakening response was associated with time to recurrence of major depressive disorder

Psychoneuroendocrinology

Volumn 50, Issue , 2014, Pages 62-71

  Hardeveld, Florian ^a   Spijker, Jan ^a,b,c   Vreeburg, Sophie A ^d   De Graaf, Ron ^b   Hendriks, Sanne M ^a   Licht, Carmilla M M ^d   Nolen, Willem A ^e   Penninx, Brenda W J H ^d   Beekman, Aartjan T F ^d  

^a Institute for Mental Health Care   (Netherlands)

^b NETHERLANDS INSTITUTE OF MENTAL HEALTH AND ADDICTION   (Netherlands)

^c RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

HPA axis recurrence major depressive disorder

Indexed keywords

ANTIDEPRESSANT AGENT; HYDROCORTISONE;

ADULT; AGED; ANXIETY DISORDER; AREA UNDER THE CURVE; AROUSAL; ARTICLE; CHEMILUMINESCENCE IMMUNOASSAY; CHILDHOOD TRAUMA; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CORTISOL AWAKENING RESPONSE; DEXAMETHASONE SUPPRESSION TEST; DISEASE SEVERITY; DSM-IV; ENDOCRINE FUNCTION TEST; FAMILY HISTORY; FEMALE; HUMAN; HYPERACTIVITY; HYPOACTIVITY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INJURY; LIFE EVENT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PREVALENCE; PROSPECTIVE STUDY; RECURRENT DISEASE; RISK FACTOR; SALIVA ANALYSIS; SMOKING; STRESS; CHEMISTRY; CIRCADIAN RHYTHM; DEPRESSIVE DISORDER, MAJOR; HYPOPHYSIS ADRENAL SYSTEM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; SALIVA; TIME; WAKEFULNESS;

ADULT; CIRCADIAN RHYTHM; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM; RECURRENCE; SALIVA; TIME FACTORS; WAKEFULNESS;

EID: 84908428896     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2014.07.027     Document Type: Article

References (58)

1. Adam E.K., Doane L.D., Zinbarg R.E., Mineka S., Craske M.G., Griffith J.W. Prospective prediction of major depressive disorder from cortisol awakening responses in adolescence. Psychoneuroendocrinology 2010, 35(6):921-931.
2. Aihara M., Ida I., Yuuki N., Oshima A., Kumano H., Takahashi K., Fukuda M., Oriuchi N., Endo K., Matsuda H., Mikuni M. HPA axis dysfunction in unmedicated major depressive disorder and its normalization by pharmacotherapy correlates with alteration of neural activity in prefrontal cortex and limbic/paralimbic regions. Psychiatry Res. 2007, 155(3):245-256.
3. Appelhof B.C., Huyser J., Verweij M., Brouwer J.P., van Dyck R., Fliers E., Hoogendijk W.J., Tijssen J.G., Wiersinga W.M., Schene A.H. Glucocorticoids and relapse of major depression (dexamethasone/corticotropin-releasing hormone test in relation to relapse of major depression). Biol. Psychiatry 2006, 59(8):696-701.
4. Aubry J.M., Gervasoni N., Osiek C., Perret G., Rossier M.F., Bertschy G., Bondolfi G. The DEX/CRH neuroendocrine test and the prediction of depressive relapse in remitted depressed outpatients. J. Psychiatr. Res. 2007, 41(3-4):290-294.
5. Baes C.V.W., Tofoli S.M.C., Martins C.M.S., Juruena M.F. Assessment of the hypothalamic-pituitary-adrenal axis activity: glucocorticoid receptor and mineralocorticoid receptor function in depression with early life stress - a systematic review. Acta Neuropsychiatr. 2012, 24(1):4-15.
6. Bhagwagar Z., Hafizi S., Cowen P.J. Increase in concentration of waking salivary cortisol in recovered patients with depression. Am. J. Psychiatry 2003, 160(10):1890-1891.
7. Bhagwagar Z., Cowen P.J. 'It's not over when it's over': persistent neurobiological abnormalities in recovered depressed patients. Psychol. Med. 2008, 38(3):307-313.
8. Bockting C.L., Lok A., Visser I., Assies J., Koeter M.W., Schene A.H. Lower cortisol levels predict recurrence in remitted patients with recurrent depression: a 5.5 year prospective study. Psychiatry Res. 2012, 200(2-3):281-287. DELTA Study Group.
9. Brugha T., Bebbington P., Tennant C., Hurry J. The list of threatening experiences: a subset of 12 life event categories with considerable long-term contextual threat. Psychol. Med. 1985, 15(1):189-194.
10. Buchanan T.W., Kern S., Allen J.S., Tranel D., Kirschbaum C. Circadian regulation of cortisol after hippocampal damage in humans. Biol. Psychiatry 2004, 56(9):651-656.
11. Burcusa S.L., Iacono W.G. Risk for recurrence in depression. Clin. Psychol. Rev. 2007, 27(8):959-985.
12. Carroll B.J., Feinberg M., Greden J.F., Tarika J., Albala A.A., Haskett R.F., James N.M., Kronfol Z., Lohr N., Steiner M., de Vigne J.P., Young E. A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility. Arch. Gen. Psychiatry 1981, 38(1):15-22.
13. Clow A., Hucklebridge F., Thorn L. The cortisol awakening response in context. Int. Rev. Neurobiol. 2010, 93:153-175.
14. De Graaf R., Bijl R.V., ten Have M., Beekman A.T., Vollebergh W.A. Pathways to comorbidity: the transition of pure mood, anxiety and substance use disorders into comorbid conditions in a longitudinal population-based study. J. Affect. Disord. 2004, 82(3):461-467.
15. Fries E., Dettenborn L., Kirschbaum C. The cortisol awakening response (CAR): facts and future directions. Int. J. Psychophysiol. 2009, 72(1):67-73.
16. Furukawa T.A., Fujita A., Harai H., Yoshimura R., Kitamura T., Takahashi K. Definitions of recovery and outcomes of major depression: results from a 10-year follow-up. Acta Psychiatr. Scand. 2008, 117(1):35-40.
17. Fyer A.J., Weissman M.M. Genetic linkage study of panic: clinical methodology and description of pedigrees. Am. J. Med. Genet. 1999, 88(2):173-181.
18. Gueorguieva R., Krystal J.H. Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry. Arch. Gen. Psychiatry 2004, 61(3):310-317.
19. Hardeveld F., Spijker J., de Graaf R., Nolen W.A., Beekman A.T. Prevalence and predictors of recurrence of major depressive disorder in the adult population. Acta Psychiatr. Scand. 2010, 122(3):184-191.
20. Harris T.O., Borsanyi S., Messari S., Stanford K., Cleary S.E., Shiers H.M., Brown G.W., Herbert J. Morning cortisol as a risk factor for subsequent major depressive disorder in adult women. Br. J. Psychiatry 2000, 177:505-510.
21. Hatzinger M., Hemmeter U.M., Baumann K., Brand S., Holsboer-Trachsler E. The combined DEX-CRH test in treatment course and long-term outcome of major depression. J. Psychiatr. Res. 2002, 36(5):287-297.
22. Hellhammer J., Fries E., Schweisthal O.W., Schlotz W., Stone A.A., Hagemann D. Several daily measurements are necessary to reliably assess the cortisol rise after awakening: state- and trait components. Psychoneuroendocrinology 2007, 32(1):80-86.
23. Holleman M., Vreeburg S.A., Dekker J.J., Penninx B.W. The relationships of working conditions, recent stressors and childhood trauma with salivary cortisol levels. Psychoneuroendocrinology 2012, 37(6):801-809.
24. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 2000, 23(5):477-501.
25. Hovens J.G., Wiersma J.E., Giltay E.J., van Oppen P., Spinhoven P., Penninx B.W., Zitman F.G. Childhood life events and childhood trauma in adult patients with depressive, anxiety and comorbid disorders vs. controls. Acta Psychiatr. Scand. 2010, 122(1):66-74.
26. Judd L.L. The clinical course of unipolar major depressive disorders. Arch. Gen. Psychiatry 1997, 54(11):989-991.
27. Kaestner F., Hettich M., Peters M., Sibrowski W., Hetzel G., Ponath G., Arolt V., Cassens U., Rothermundt M. Different activation patterns of proinflammatory cytokines in melancholic and non-melancholic major depression are associated with HPA axis activity. J. Affect. Disord. 2005, 87(2-3):305-311.
28. Kirschbaum C., Hellhammer D.H. Salivary cortisol in psychobiological research: an overview. Neuropsychobiology 1989, 22(3):150-169.
29. Lok A., Mocking R.J., Ruhé H.G., Visser I., Koeter M.W., Assies J., Bockting C.L., Olff M., Schene A.H. Longitudinal hypothalamic-pituitary-adrenal axis trait and state effects in recurrent depression. Psychoneuroendocrinology 2012, 37(7):892-902.
30. Lyketsos C.G., Nestadt G., Cwi J., Heithoff K., Eaton W.W. The life-chart method to describe the course of psychopathology. Int. J. Methods Psychiatr. Res. 1994, 4:143-155.
31. Mannie Z.N., Harmer C.J., Cowen P.J. Increased waking salivary cortisol levels in young people at familial risk of depression. Am. J. Psychiatry 2007, 164(4):617-621.
32. McKay M.S., Zakzanis K.K. The impact of treatment on HPA axis activity in unipolar major depression. J. Psychiatr. Res. 2010, 44(3):183-192.
33. Morris M.C., Rao U., Garber J. Cortisol responses to psychosocial stress predict depression trajectories: social-evaluative threat and prior depressive episodes as moderators. J. Affect. Disord. 2012, 143(1-3):223-230.
34. Nelson J.C., Davis J.M. DST studies in psychotic depression: a meta-analysis. Am. J. Psychiatry 1997, 154(11):1497-1503.
35. Nemeroff C.B. The corticotropin-releasing factor (CRF) hypothesis of depression: new findings and new directions. Mol. Psychiatry 1996, 1(4):336-342.
36. Pariante C.M. Risk factors for development of depression and psychosis. Glucocorticoid receptors and pituitary implications for treatment with antidepressant and glucocorticoids. Ann. N. Y. Acad. Sci. 2009, 1179:144-152.
37. Penninx B.W., Beekman A.T., Smit J.H., Zitman F.G., Nolen W.A., Spinhoven P., Cuijpers P., de Jong P.J., van Marwijk H.W., Assendelft W.J., van der Meer K., Verhaak P., Wensing M., de Graaf R., Hoogendijk W.J., Ormel J., van Dyck R. The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods. Int. J. Methods Psychiatr. Res. 2008, 17(3):121-140. NESDA Research Consortium.
38. Pintor L., Torres X., Navarro V., Martinez de Osaba M.A., Matrai S., Gastó C. Prediction of relapse in melancholic depressive patients in a 2-year follow-up study with corticotropin releasing factor test. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33(3):463-469.
39. Pruessner J.C., Wolf O.T., Hellhammer D.H., Buske-Kirschbaum A., von Auer K., Jobst S., Kaspers F., Kirschbaum C. Free cortisol levels after awakening: a reliable biological marker for the assessment of adrenocortical activity. Life Sci. 1997, 61(26):2539-2549.
40. Pruessner J.C., Kirschbaum C., Meinlschmid G., Hellhammer D.H. Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology 2003, 28(7):916-931.
41. Pruessner M., Pruessner J.C., Hellhammer D.H., Bruce Pike G., Lupien S.J. The associations among hippocampal volume, cortisol reactivity, and memory performance in healthy young men. Psychiatry Res. 2007, 155(1):1-10.
42. Rao U., Hammen C.L., Poland R.E. Longitudinal course of adolescent depression: neuroendocrine and psychosocial predictors. J. Am. Acad. Child Adolesc. Psychiatry 2010, 49(2):141-151.
43. Ribeiro S.C., Tandon R., Grunhaus L., Greden J.F. The DST as a predictor of outcome in depression: a meta-analysis. Am. J. Psychiatry 1993, 150(11):1618-1629.
44. Rush A.J., Gullion C.M., Basco M.R., Jarrett R.B., Trivedi M.H. The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol. Med. 1996, 26(3):477-486.
45. Shea A., Walsh C., Macmillan H., Steiner M. Child maltreatment and HPA axis dysregulation: relationship to major depressive disorder and post traumatic stress disorder in females. Psychoneuroendocrinology 2005, 30(2):162-178.
46. Stetler C., Miller G.E. Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research. Psychosom. Med. 2011, 73(2):114-126.
47. Van Aken M.O., Romijn J.A., Miltenburg J.A., Lentjes E.G. Automated measurement of salivary cortisol. Clin. Chem. 2003, 49(8):1408-1409.
48. Vreeburg S.A., Kruijtzer B.P., van Pelt J., van Dyck R., de Rijk R.H., Hoogendijk W.J., Smit J.H., Zitman F.G., Penninx B.W. Associations between sociodemographic, sampling and health factors and various salivary cortisol indicators in a large sample without psychopathology. Psychoneuroendocrinology 2009, (8):1109-1120.
49. Vreeburg S.A., Hoogendijk W.J., van Pelt J., Derijk R.H., Verhagen J.C., van Dyck R., Smit J.H., Zitman F.G., Penninx B.W. Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study. Arch. Gen. Psychiatry 2009, 66(6):617-626.
50. Vreeburg S.A., Hartman C.A., Hoogendijk W.J., van Dyck R., Zitman F.G., Ormel J., Penninx B.W. Parental history of depression or anxiety and the cortisol awakening response. Br. J. Psychiatry 2010, 197(3):180-185.
51. Vreeburg S.A., Hoogendijk W.J., de Rijk R.H., van Dyck R., Smit J.H., Zitman F.G., Penninx B.W. Salivary cortisol levels and the 2-year course of depressive and anxiety disorders. Psychoneuroendocrinology 2013, 38(9):1494-1502.
52. Vrshek-Schallhorn S., Doane L.D., Mineka S., Zinbarg R.E., Craske M.G., Adam E.K. The cortisol awakening response predicts major depression: predictive stability over a 4-year follow-up and effect of depression history. Psychol. Med. 2013, 43(3):483-493.
53. Wiersma J.E., Hovens J.G., van Oppen P., Giltay E.J., van Schaik D.J., Beekman A.T., Penninx B.W. The importance of childhood trauma and childhood life events for chronicity of depression in adults. J. Clin. Psychiatry 2009, 70(7):983-989.
54. World Health Organization Composite International Diagnostic Interview. Core Version 2.1: Interview's Manual 1997, World Health Organisation, Sydney, Australia.
55. World Health Organization The Global Burden of Disease: 2004 Update 2008, World Health Organisation, Geneva.
56. Wüst S., Federenko I., Hellhammer D.H., Kirschbaum C. Genetic factors, perceived chronic stress, and the free cortisol response to awakening. Psychoneuroendocrinology 2000, 25(7):707-720.
57. Zobel A.W., Yassouridis A., Frieboes R.M., Holsboer F. Prediction of medium-term outcome by cortisol response to the combined dexamethasone-CRH test in patients with remitted depression. Am. J. Psychiatry 1999, 156(6):949-951.
58. Zobel A.W., Nickel T., Sonntag A., Uhr M., Holsboer F., Ising M. Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. a prospective study. J. Psychiatr. Res. 2001, 35(2):83-94.